Document is current
Any future updates will be listed below
-
Authors
Barth, Claudia https://orcid.org/0000-0001-6544-0945
Kelly, Sinead
Nerland, Stener
Jahanshad, Neda
Alloza, Clara
Ambrogi, Sonia https://orcid.org/0000-0002-2897-358X
Andreassen, Ole A. https://orcid.org/0000-0002-4461-3568
Andreou, Dimitrios
Arango, Celso https://orcid.org/0000-0003-3382-4754
Baeza, Inmaculada
Banaj, Nerisa
Bearden, Carrie E. https://orcid.org/0000-0002-8516-923X
Berk, Michael
Bohman, Hannes
Castro-Fornieles, Josefina https://orcid.org/0000-0003-0632-2687
Chye, Yann
Crespo-Facorro, Benedicto
de la Serna, Elena
Díaz-Caneja, Covadonga M. https://orcid.org/0000-0001-8538-3175
Gurholt, Tiril P. https://orcid.org/0000-0002-1272-7616
Hegarty, Catherine E.
James, Anthony https://orcid.org/0000-0002-2742-8328
Janssen, Joost https://orcid.org/0000-0001-7613-2067
Johannessen, Cecilie
Jönsson, Erik G.
Karlsgodt, Katherine H.
Kochunov, Peter
Lois, Noemi G.
Lundberg, Mathias
Myhre, Anne M.
Pascual-Diaz, Saül
Piras, Fabrizio https://orcid.org/0000-0003-3566-5494
Smelror, Runar E.
Spalletta, Gianfranco https://orcid.org/0000-0002-7432-4249
Stokkan, Therese S.
Sugranyes, Gisela https://orcid.org/0000-0002-2545-7862
Suo, Chao https://orcid.org/0000-0002-9358-6690
Thomopoulos, Sophia I.
Tordesillas-Gutiérrez, Diana https://orcid.org/0000-0003-1458-3932
Vecchio, Daniela https://orcid.org/0000-0001-8428-7376
Wedervang-Resell, Kirsten
Wortinger, Laura A. https://orcid.org/0000-0003-2721-3172
Thompson, Paul M.
Agartz, Ingrid
- License Information
-
More Information
Article History
Received: 22 April 2022
Revised: 16 November 2022
Accepted: 21 November 2022
First Online: 12 December 2022
Competing interests
: For work unrelated to the contents of this manuscript, the following authors received funding from third-parties. Celso Arango: has been a consultant to or has received honoraria or grants from Acadia, Angelini, Gedeon Richter, Janssen Cilag, Lundbeck, Medscape, Otsuka, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion, and Takeda; Inmaculada Baeza: has received honoraria and travel support from Angelini, Otsuka-Lundbeck and Janssen. Michael Berk: was supported by an unrestricted grant from AstraZeneca; Covadonga M. Díaz-Caneja: has received honoraria from Exeltis and Angelini; Gisela Sugranyes has received honoraria from Angelini; Paul M. Thompson, Neda Jahanshad: MPI of a research grant from Biogen, Inc.; Ole A. Andreassen: has received speaker’s honorarium from Lundbeck and is a consultant to HealthLytix. Claudia Barth, Sinead Kelly, Stener Nerland, Clara Alloza, Sonia Ambrogi, Dimitrios Andreou, Nerisa Banaj, Carrie E. Bearden, Hannes Bohman, Josefina Castro-Fornieles, Yann Chye, Benedicto Crespo-Facorro, Elena de la Serna, Tiril P. Gurholt, Catherine E. Hegarty, Anthony James, Joost Janssen, Cecilie Johannessen, Erik G. Jönsson, Katherine H. Karlsgodt, Peter Kochunov, Noemi G Lois, Mathias Lundberg, Anne M. Myhre, Saül Pascual-Diaz, Fabrizio Piras, Runar E. Smelror, Gianfranco Spalletta, Therese S. Stokkan, Chao Suo, Sophia I. Thomopoulos, Diana Tordesillas-Gutiérrez, Daniela Vecchio, Kirsten Wedervang-Resell, Laura A. Wortinger, and Ingrid Agartz reported no biomedical financial interests or potential conflicts of interest.
